$15.67
-0.61-3.75%
At Close: -
$15.67
00.00%
After Hours: 4:01 PM EDT
15 minutes delayed
Comments
Loading...
Inhibrx Biosciences (NASDAQ:INBX) Stock, Earnings Estimates, EPS, And Revenue
Inhibrx Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 13
EPS
$125.480
Quarterly Revenue
$100K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$1.7M
Analyze the earnings history of Inhibrx Biosciences using advanced sorting and filters.
Data brought to you by Benzinga APIs
Inhibrx Biosciences (INBX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-13 | $125.48 | $-1.47 | 8636.0 % |
| Mar 2024 | 2024-05-09 | $-1.44 | $-1.51 | 4.64 % |
| Dec 2023 | 2024-02-28 | $-1.73 | $-1.04 | -66.3 % |
| Sep 2023 | 2023-11-09 | $-1.10 | $-1.01 | -8.91 % |
Inhibrx Biosciences (INBX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-02-28 | $1.63M | $50.00K | 3168.0 % |
| Mar 2023 | 2023-05-08 | $17.00K | $150.00K | -88.7 % |
| Dec 2022 | 2023-03-06 | $274.00K | $790.00K | -65.3 % |
| Sep 2022 | 2022-11-07 | $278.00K | $630.00K | -55.9 % |
FAQ
When is Inhibrx Biosciences (NASDAQ:INBX) reporting earnings?
Inhibrx Biosciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 13, 2024 for Q2.
What were the latest earnings per share (EPS) for Inhibrx Biosciences (NASDAQ:INBX)?
Inhibrx Biosciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 13, 2024 for Q2 and the Actual EPS was $125.48, which beat the estimate of $-1.47.
What were Inhibrx Biosciences’s (NASDAQ:INBX) revenues?
Inhibrx Biosciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 13, 2024 for Q2 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.